Literature DB >> 11900551

Role of aromatic side chains in the binding of volatile general anesthetics to a four-alpha-helix bundle.

Gavin A Manderson1, Jonas S Johansson.   

Abstract

Currently, the mechanism by which anesthesia occurs is thought to involve the direct binding of inhaled anesthetics to ligand-gated ion channels. This hypothesis is being studied using four-alpha-helix bundles as model systems for the transmembrane domains of the natural "receptor" proteins. This study concerns the role in anesthetic binding played by aromatic side chains in the binding cavity of a four-alpha-helix bundle designed to assume a Rop-like fold. Specifically, the effect of the substitution W15Y on bundle structure, stability, and anesthetic binding energetics was investigated. No appreciable effect of substituting W for Y on the secondary structure or the thermodynamic stability of the four-alpha-helix bundle was identified. However, the substitution W15Y resulted in about 6- and 3-fold decreases in halothane and chloroform binding affinities, respectively. This effect may reflect weaker dipole-aromatic quadrupole interactions between the aromatic side chain and the anesthetic in the tyrosine-containing species, which possesses the smaller aromatic ring system. For these anesthetic binding proteins, this class of interaction occurs when the permanent nonspherical distribution of electrons in the aromatic ring systems interact with the weakly acidic CH group of the anesthetics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900551     DOI: 10.1021/bi0160718

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  A model membrane protein for binding volatile anesthetics.

Authors:  Shixin Ye; Joseph Strzalka; Inna Y Churbanova; Songyan Zheng; Jonas S Johansson; J Kent Blasie
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

2.  Truncated human serum albumin retains general anaesthetic binding activity.

Authors:  Renyu Liu; Jinsheng Yang; Chung-Eun Ha; Nadhipuram V Bhagavan; Roderic G Eckenhoff
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

3.  Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studies.

Authors:  Pravat K Mandal; Jay W Pettegrew; Dennish W McKeag; Ratna Mandal
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

4.  Monolayers of a model anesthetic-binding membrane protein: formation, characterization, and halothane-binding affinity.

Authors:  Inna Y Churbanova; Andrey Tronin; Joseph Strzalka; Thomas Gog; Ivan Kuzmenko; Jonas S Johansson; J Kent Blasie
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

5.  Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1.

Authors:  Koichi Yuki; Nathan S Astrof; Clay Bracken; Sulpicio G Soriano; Motomu Shimaoka
Journal:  Anesthesiology       Date:  2010-09       Impact factor: 7.892

6.  The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity.

Authors:  Koichi Yuki; Nathan S Astrof; Clay Bracken; Ronnie Yoo; Whitney Silkworth; Sulpicio G Soriano; Motomu Shimaoka
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

7.  An isothermal titration calorimetry study on the binding of four volatile general anesthetics to the hydrophobic core of a four-alpha-helix bundle protein.

Authors:  Tao Zhang; Jonas S Johansson
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.